Factors associated with positive and negative recommendations for cancer and non-cancer drugs for rare diseases in Canada

In Canada, reimbursement recommendations on drugs for common and rare diseases are overseen by the Canadian Agency for Drugs and Technologies in Health (CADTH) and made through the pan-Canadian Oncology Drug R...

Source: Orphanet Journal of Rare Diseases - June 7, 2019 Category: Internal Medicine Authors: Fernanda Naomi Inagaki Nagase, Tania Stafinski, Jian Sun, Gian Jhangri and Devidas Menon Tags: Research Source Type: research